Topical steroids play key role in psoriasis treatment – know the hazards and benefits

1. Gregoire ARF, DeRuyter BK, Stratman EJ. Psoriasis flares following systemic glucocorticoid exposure in patients with a history of psoriasis. JAMA Dermatol 2021;157(2):198–201.

2. Mason AR, Mason J, Cork M, et al. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev 2013;(3):CD005028.

3. Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol 2021;84(2):432–70.

4. Thomas M, Wong CC, Anderson P, et al. Magnitude, characteristics and consequences of topical steroid misuse in rural North India: an observational study among dermatology outpatients. BMJ Open 2020;10(5):e032829.

5. Shrestha S, Joshi S, Bhandari S. Prevalence of misuse of topical corticosteroid among dermatology outpatients. JNMA J Nepal Med Assoc 2020;58(231):834–38.

6. Lahiri K, Coondoo A. Topical steroid damaged/dependent face (TSDF): An entity of cutaneous pharmacodependence. Indian J Dermatol 2016;61(3):265–72.

7. Ministry of Health. Pharmaceutical data web tool, version 3 August 2020. https://bit.ly/2NYY9xY